Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Regulatory
  • FDA, Moderna appear aligned on mRNA flu shot heading into adcomm
  • Regulatory

FDA, Moderna appear aligned on mRNA flu shot heading into adcomm

BioSpace

The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna's seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in Febru

Infectious Disease

Read full story

pharminent June 16, 2026

BioSpace

The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna’s seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in Febru

Infectious Disease

Read full story

Post navigation

Previous: German said to be backtracking on pharma rebate changes
Next: EHA26: BMS touts positive multiple myeloma data for two pipeline candidates

Related Stories

  • Regulatory

Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion

pharminent September 10, 2026
  • Regulatory

HHS appoints permanent FDA CBER, CDER heads

pharminent September 10, 2026
  • Regulatory

FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer

pharminent September 7, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.